5 trends tracked about this subject — the full history, oldest to newest below.
New research suggests some infants diagnosed with peanut allergy may outgrow it within months, challenging long-held assumptions about the condition's permanence.
Early research indicates GLP-1 weight-loss drugs may slow biological aging by up to four years, according to recent coverage.
Recent studies examine connections between smartphone access at age twelve and subsequent eating disorder symptoms by age fourteen.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Capricor Therapeutics faces investor investigations and biotech sector scrutiny ahead of an anticipated August decision.